Related Experiment Video
Updated: Sep 10, 2025

16:41
Experimental Approaches to Tissue Engineering
Published on: August 30, 2007
6.5K
Navigating Medical Device Safety: Current Status, Challenges, and Future Regulatory Directions.
Omar Aimer1,2,3, Catherine Baldridge4,5
1InnoVigilance International Academy, Laval, QC, Canada. omar.aimer@innovigilance.com.
Drug Safety
|August 20, 2025
Summary
Ensuring medical device safety is crucial, especially with complex technologies like AI. This paper reviews current safety challenges, regulatory efforts, and proposes innovative solutions for better postmarket surveillance and global collaboration.
Area of Science:
- Healthcare technology
- Regulatory science
- Patient safety
Background:
- Medical devices are vital for healthcare, but increasing complexity, especially with AI, poses safety risks.
- Vulnerabilities in interconnected devices can lead to adverse events, impacting patient health.
- Global regulatory efforts face challenges due to fragmented reporting and monitoring systems.
Purpose of the Study:
- To explore the current landscape of medical device safety and regulatory frameworks.
- To identify challenges in data collection, reporting, and postmarket surveillance (PMS).
- To examine emerging technologies and international harmonization efforts for enhanced safety.
Main Methods:
- Review of current regulatory frameworks and reporting systems for medical devices.
- Analysis of challenges in postmarket surveillance and data fragmentation.
- Exploration of technological solutions like AI and blockchain for safety monitoring.
- Examination of international harmonization initiatives by organizations like IMDRF, ISoP, and WHO.
Main Results:
- Disparities in global reporting systems hinder effective safety oversight.
- Postmarket surveillance is critical for identifying real-world device risks.
- Emerging technologies and international collaboration offer potential improvements in safety monitoring.
- Harmonization efforts aim to standardize practices and improve global cooperation.
Conclusions:
- Leveraging real-world data, enhancing cybersecurity, and fostering international cooperation are key recommendations.
- Addressing data fragmentation and underreporting is essential for robust medical device safety.
- Integrating innovative technologies and collaborative efforts can enhance monitoring and mitigate risks.
- Collective action is vital to ensure advanced healthcare through safe medical devices and improve global health outcomes.
Related Concept Videos
Drug Regulation
1.8K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.8K
Pharmacovigilance
989
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
989
Drug Control Governance: Regulatory Bodies and Their Impact
241
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
241
Bacterial Signaling
34.1K
Bacterial signaling can occur within bacteria (intracellular) or between bacteria (intercellular). At times, a group of bacteria behaves like a community. To achieve this, they engage in quorum sensing, the perception of higher cell density that causes changes in gene expression. Quorum sensing involves both extracellular and intracellular signaling. The signaling cascade starts with a molecule called an autoinducer (AI). Individual bacteria produce AIs that move out of the bacterial cell...
34.1K
Issues And Trends In Healthcare Delivery System
5.8K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
5.8K
Clinical Trials
8.1K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
8.1K

